Literature DB >> 23081841

β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury.

Bibo Ke1, Xiu-Da Shen, Naoko Kamo, Haofeng Ji, Shi Yue, Feng Gao, Ronald W Busuttil, Jerzy W Kupiec-Weglinski.   

Abstract

UNLABELLED: Dendritic cells (DCs) are critical mediators of immune responses that integrate signals from the innate immune system to orchestrate adaptive host immunity. This study was designed to investigate the role and molecular mechanisms of STAT3-induced β-catenin in the regulation of DC function and inflammatory responses in vitro and in vivo. STAT3 induction in lipopolysaccharide (LPS)-stimulated mouse bone marrow-derived DCs (BMDCs) triggered β-catenin activation by way of GSK-3β phosphorylation. The activation of β-catenin inhibited phosphatase and tensin homolog delete on chromosome 10 (PTEN) and promoted the phosphoinositide 3-kinase (PI3K)/Akt pathway, which in turn down-regulated DC maturation and function. In contrast, knockdown of β-catenin increased PTEN/TLR4 (Toll-like receptor 4), interferon regulatory factor-3 (IRF3), nuclear factor kappa B (NF-κB) activity, and proinflammatory cytokine programs in response to LPS stimulation. In a mouse model of warm liver ischemia and reperfusion injury (IRI), disruption of β-catenin signaling increased the hepatocellular damage, enhanced hepatic DC maturation/function, and PTEN/TLR4 local inflammation in vivo.
CONCLUSION: These findings underscore the role of β-catenin to modulate DC maturation and function at the innate-adaptive interface. Activation of β-catenin triggered PI3K/Akt, which in turn inhibited TLR4-driven inflammatory response in a negative feedback regulatory mechanism. By identifying the molecular pathways by which β-catenin regulates DC function, our findings provide the rationale for novel therapeutic approaches to manage local inflammation and injury in IR-stressed liver.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23081841      PMCID: PMC3594407          DOI: 10.1002/hep.26100

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  A critical role for Stat3 signaling in immune tolerance.

Authors:  Fengdong Cheng; Hong-Wei Wang; Alex Cuenca; Mei Huang; Tomar Ghansah; Jason Brayer; William G Kerr; Kiyoshi Takeda; Shizuo Akira; Stephen P Schoenberger; Hua Yu; Richard Jove; Eduardo M Sotomayor
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

Review 2.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 3.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 4.  Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice.

Authors:  T Kaisho; S Akira
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

5.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 6.  PI3K and negative regulation of TLR signaling.

Authors:  Taro Fukao; Shigeo Koyasu
Journal:  Trends Immunol       Date:  2003-07       Impact factor: 16.687

7.  Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

Authors:  Masaya Kobayashi; Mi-Na Kweon; Hirotaka Kuwata; Robert D Schreiber; Hiroshi Kiyono; Kiyoshi Takeda; Shizuo Akira
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Liver dendritic cells present bacterial antigens and produce cytokines upon Salmonella encounter.

Authors:  Cecilia Johansson; Mary Jo Wick
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  34 in total

1.  Hippo Signaling Controls NLR Family Pyrin Domain Containing 3 Activation and Governs Immunoregulation of Mesenchymal Stem Cells in Mouse Liver Injury.

Authors:  Changyong Li; Yuting Jin; Song Wei; Yishuang Sun; Longfeng Jiang; Qiang Zhu; Douglas G Farmer; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Bibo Ke
Journal:  Hepatology       Date:  2019-06-21       Impact factor: 17.425

2.  LGR4 protects hepatocytes from injury in mouse.

Authors:  Ziru Li; Shiying Liu; Jianing Lou; Michael Mulholland; Weizhen Zhang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-08       Impact factor: 4.052

3.  Phosphatase and tensin homolog-β-catenin signaling modulates regulatory T cells and inflammatory responses in mouse liver ischemia/reperfusion injury.

Authors:  Qiang Zhu; Changyong Li; Kunpeng Wang; Shi Yue; Longfeng Jiang; Michael Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Feng Zhang; Ling Lu; Bibo Ke
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

4.  CO(2) pneumoperitoneum increases secretory IgA levels in the gut compared with laparotomy in an experimental animal model.

Authors:  Toru Kusano; Tsuyoshi Etoh; Masafumi Inomata; Norio Shiraishi; Seigo Kitano
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

5.  The myeloid heat shock transcription factor 1/β-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury.

Authors:  Shi Yue; Jianjun Zhu; Ming Zhang; Changyong Li; Xingliang Zhou; Min Zhou; Michael Ke; Ronald W Busuttil; Qi-Long Ying; Jerzy W Kupiec-Weglinski; Qiang Xia; Bibo Ke
Journal:  Hepatology       Date:  2016-08-29       Impact factor: 17.425

6.  WNT ligands contribute to the immune response during septic shock and amplify endotoxemia-driven inflammation in mice.

Authors:  Marcela Gatica-Andrades; Dimitrios Vagenas; Jessica Kling; Tam T K Nguyen; Helen Benham; Ranjeny Thomas; Heinrich Körner; Bala Venkatesh; Jeremy Cohen; Antje Blumenthal
Journal:  Blood Adv       Date:  2017-07-10

Review 7.  Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

Authors:  Ling Lu; Haoming Zhou; Ming Ni; Xuehao Wang; Ronald Busuttil; Jerzy Kupiec-Weglinski; Yuan Zhai
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

8.  WNT/β-catenin signaling regulates cigarette smoke-induced airway inflammation via the PPARδ/p38 pathway.

Authors:  Lingli Guo; Tao Wang; Yanqiu Wu; Zhicheng Yuan; Jiajia Dong; Xiao'ou Li; Jing An; Zenglin Liao; Xue Zhang; Dan Xu; Fu-Qiang Wen
Journal:  Lab Invest       Date:  2015-08-31       Impact factor: 5.662

9.  Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.

Authors:  Michael A Zimmerman; Eunyoung Tak; Stefan F Ehrentraut; Maria Kaplan; Antasia Giebler; Tingting Weng; Doo-Sup Choi; Michael R Blackburn; Igal Kam; Holger K Eltzschig; Almut Grenz
Journal:  Hepatology       Date:  2013-09-24       Impact factor: 17.425

10.  KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.

Authors:  Bibo Ke; Xiu-Da Shen; Yu Zhang; Haofeng Ji; Feng Gao; Shi Yue; Naoko Kamo; Yuan Zhai; Masayuki Yamamoto; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2013-07-16       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.